HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ASCC3
activating signal cointegrator 1 complex subunit 3
Chromosome 6 Β· 6q16.3
NCBI Gene: 10973Ensembl: ENSG00000112249.15HGNC: HGNC:18697UniProt: B4DR60
151PubMed Papers
21Diseases
0Drugs
13Pathogenic Variants
FUNCTIONAL ROLE
DNA Repair
RESEARCH IMPACT
Trending
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
cytosolic ribosomecytosolprotein bindingRQC-trigger complexintellectual developmental disorder, autosomal recessive 81major depressive disordersmoking initiationnephrolithiasis
✦AI Summary

ASCC3 is a multifunctional ATPase and 3'-5' DNA helicase with roles in DNA repair, ribosome quality control, and transcriptional regulation. As a component of the ASC-1 complex, ASCC3 functions in alkylated DNA repair by promoting DNA unwinding to generate single-stranded substrates for ALKBH3-mediated processing of alkylated bases 1. ASCC3 is a critical ribosome quality control factor that disassembles collided ribosomes in an ATP-dependent, ZNF598-ubiquitination-dependent manner as part of the ribosome-associated quality control (RQC) pathway 2. During replication stress, ASCC3 is recruited to stalled replication forks via ASCC2 and unwinds DNA to promote fork reversal and ATR activation while antagonizing RAD51-mediated recombination 3. Beyond DNA metabolism, ASCC3 participates in transcriptional regulation through ASC-1 complex-mediated NF-ΞΊB, SRF, and AP1 transactivation 4. In cancer contexts, elevated ASCC3 expression promotes non-small cell lung cancer progression by stabilizing STAT3 signaling through CAND1-mediated inhibition of STAT3 ubiquitination, suppressing interferon responses and inducing immunosuppression 5. Conversely, ASCC3 activation ameliorates fragile X syndrome phenotypes by restoring collided ribosome handling in the absence of FMRP 6. ASCC3 dysfunction is associated with intellectual developmental disorder and chr6 hepatitis B susceptibility 7.

Sources cited
1
ASCC3 is a 3'-5' DNA helicase involved in alkylated DNA repair by promoting DNA unwinding for ALKBH3-mediated N3-methylcytosine processing
PMID: 22055184
2
ASCC3 helicase within the ASC-1 complex disassembles collided ribosomes in ATP-dependent and ZNF598-ubiquitination-dependent manner
PMID: 32579943
3
ASCC3 is recruited to stalled replication forks and unwinds DNA to promote fork reversal, RPA accumulation, and ATR activation while antagonizing RAD51
PMID: 40777259
4
ASCC3 as part of ASC-1 complex enhances NF-ΞΊB, SRF, and AP1 transactivation
PMID: 12077347
5
ASCC3 upregulation in non-small cell lung cancer promotes immunosuppression by stabilizing STAT3 via CAND1-mediated inhibition of ubiquitin-dependent STAT3 degradation
PMID: 38148115
6
ASCC3 activation ameliorates fragile X syndrome phenotypes by restoring collided ribosome handling through FMRP-ASCC3 interaction
PMID: 41061044
7
ASCC3 gene polymorphism rs10485138 is associated with chronic hepatitis B susceptibility in Han Chinese females
PMID: 26536629
Disease Associationsβ“˜21
intellectual developmental disorder, autosomal recessive 81Open Targets
0.69Moderate
major depressive disorderOpen Targets
0.45Moderate
smoking initiationOpen Targets
0.41Moderate
nephrolithiasisOpen Targets
0.34Weak
insomniaOpen Targets
0.31Weak
bipolar disorderOpen Targets
0.31Weak
congenital myopathyOpen Targets
0.30Weak
chronic venous hypertensionOpen Targets
0.29Weak
sleep apneaOpen Targets
0.28Weak
glomerulonephritisOpen Targets
0.28Weak
obesityOpen Targets
0.27Weak
post-traumatic stress disorderOpen Targets
0.27Weak
Abnormality of the skeletal systemOpen Targets
0.26Weak
Back painOpen Targets
0.26Weak
retinal degenerationOpen Targets
0.26Weak
acute cystitisOpen Targets
0.23Weak
Abruptio PlacentaeOpen Targets
0.21Weak
device complicationOpen Targets
0.20Weak
ovarian dysfunctionOpen Targets
0.20Weak
genetic disorderOpen Targets
0.19Weak
Intellectual developmental disorder, autosomal recessive 81UniProt
Pathogenic Variants13
NM_006828.4(ASCC3):c.1597-2A>GLikely pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜…β˜…β˜†β˜†2024
NM_006828.4(ASCC3):c.802-2A>CLikely pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜…β˜†β˜†β˜†2024
NM_006828.4(ASCC3):c.5769_5770del (p.Cys1924fs)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜…β˜†β˜†β˜†2024β†’ Residue 1924
NM_006828.4(ASCC3):c.3101T>A (p.Leu1034Ter)Likely pathogenic
ASCC3-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 1034
NM_006828.4(ASCC3):c.801+1G>TLikely pathogenic
See cases|Intellectual developmental disorder, autosomal recessive 81|Gastric cancer
β˜…β˜†β˜†β˜†2019
NM_006828.4(ASCC3):c.4955G>A (p.Gly1652Asp)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1652
NM_006828.4(ASCC3):c.4415G>A (p.Arg1472Gln)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1472
NM_006828.4(ASCC3):c.3631C>T (p.Gln1211Ter)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1211
NM_006828.4(ASCC3):c.5281C>T (p.Arg1761Ter)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1761
NM_006828.4(ASCC3):c.4984A>T (p.Ile1662Phe)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1662
NM_006828.4(ASCC3):c.3522dup (p.Cys1175fs)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1175
NM_006828.4(ASCC3):c.4553G>A (p.Arg1518His)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2024β†’ Residue 1518
NM_006828.4(ASCC3):c.4690T>C (p.Ser1564Pro)Pathogenic
Intellectual developmental disorder, autosomal recessive 81
β˜†β˜†β˜†β˜†2011β†’ Residue 1564
View on ClinVar β†—
Related Genes
CDC5LProtein interaction100%XAB2Protein interaction100%BUD31Protein interaction100%SNW1Protein interaction100%PLRG1Protein interaction100%CRNKL1Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Bone Marrow
93%
Liver
84%
Brain
69%
Lung
68%
Ovary
55%
Gene Interaction Network
Click a node to explore
ASCC3CDC5LXAB2BUD31SNW1PLRG1CRNKL1
PROTEIN STRUCTURE
Preparing viewer…
PDB6YXQ Β· 2.70 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.68LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.59 [0.51–0.68]
RankingsWhere ASCC3 stands among ~20K protein-coding genes
  • #2,989of 20,598
    Most Researched151 Β· top quartile
  • #2,579of 5,498
    Most Pathogenic Variants13
  • #5,017of 17,882
    Most Constrained (LOEUF)0.68
Genes detectedASCC3
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.
PMID: 38148115
J Immunother Cancer Β· 2023
1.00
2
Translation stress and collided ribosomes are co-activators of cGAS.
PMID: 34111399
Mol Cell Β· 2021
0.90
3
The ASC-1 Complex Disassembles Collided Ribosomes.
PMID: 32579943
Mol Cell Β· 2020
0.80
4
p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy.
PMID: 40067902
Proc Natl Acad Sci U S A Β· 2025
0.70
5
Pan-cancer analysis reveals ASCC family promotes the cancer progression of lung adenocarcinoma.
PMID: 40594069
Sci Rep Β· 2025
0.68